在突变KRAS废除后,STAT3维持了瘤原生性
bioRxiv : the preprint server for biology
|March 10, 2025
概括
针对癌症中的KRAS突变,需要对STAT3进行联合失活,以消除恶性身份并促进瘤清除. 这种方法增强了有效的癌症治疗的免疫排斥.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤性KRAS突变是侵袭性癌症的驱动因素,但仅仅是它们的无活化不足以控制瘤.
- 胰腺管道腺癌 (PDAC) 由于在KRAS抑制后瘤的持久性而构成重大挑战.
- STAT3已涉及维持癌症干和免疫逃避,这对瘤存活至关重要.
研究的目的:
- 研究STAT3在KRAS突变癌症中维持恶性身份中的作用.
- 为了确定KRAS和STAT3的联合失活是否会导致瘤回归.
- 阐明STAT3在KRAS失活后导致癌症持续的机制.
主要方法:
- 在PDAC模型中,通过CRISPR介导的基因编辑来切除突变KRAS和STAT3.
- 在体内评估瘤进展,恶性身份和免疫排斥.
- 分析受KRAS和STAT3联合损失影响的核心转录程序.
主要成果:
- 通过CRISPR介导的突变KRAS的切除,只有当STAT3同时被禁用时,才能终止瘤的进展.
- 联合KRAS和STAT3损失破坏了关键的癌细胞转录程序,损害了小鼠的瘤生长.
- 缺乏KRAS和STAT3的瘤细胞表现出增强的免疫排斥,导致瘤清除.
结论:
- 在KRAS-ablated瘤中,STAT3作为瘤原体身份的关键执行者,而不是仅提供转化特征.
- KRAS和STAT3的联合失活破坏了癌细胞的基本程序,导致恶性身份的丧失.
- 这项研究揭示了KRAS驱动的癌症的脆弱性,表明STAT3是实现持久瘤控制的组合疗法的目标.
更多相关视频
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
23.2K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.6K
相关概念视频
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
